Investing

DIREXION DAILY S&P BIOTECH BULL 3X SHARES DIREXION DAILY S&P BIOTECH BULL 3X SHARES : LABU

LABU

Stock Data

$173.61

$3.95 (2.22%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Direxion Daily S&P Biotech Bull 3X Shares, managed by Rafferty Asset Management, is an exchange-traded fund that aims to offer three times the daily performance of the S&P Biotechnology Select Industry Index. Focusing on the U.S. equity markets, it invests in biotech and life sciences companies through stocks, derivatives, and other funds. This fund targets both growth and value stocks across various market capitalizations, making it a dynamic choice for those interested in the biotech sector.

All LABU Articles

3 Articles

Omor Ibne Ehsan | Apr 27, 2026 at 3:33 PM EDT

LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout

If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily…

David Beren | Apr 23, 2026 at 1:22 PM EDT

Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here’s How to Position Now

Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger…

Austin Smith | Jan 16, 2026 at 8:06 AM EST

Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull…